Humberto Reynales
Chia, CUN, Colombia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Characterization of vaccine viremia, attenuation reversion, and safety: Combined results from the TAK-003 dengue vaccine clinical development program.
Journal: Vaccine
Published: December 19, 2025
Establishing the First Genetic Variant Registry for Breast and Ovarian Cancer in Colombia: Insights and Implications.
Journal: Diseases (Basel, Switzerland)
Published: April 15, 2025
Immunogenicity, Safety, and Efficacy of a Tetravalent Dengue Vaccine in Children and Adolescents: An Analysis by Age Group.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 12, 2024
Does performing a Point-Of-Care HbA1c test increase the chances of undertaking an OGTT among individuals at risk of diabetes? A randomized controlled trial.
Journal: Primary care diabetes
Published: January 22, 2024
Cost of dengue in Colombia: A systematic review.
Journal: PLoS neglected tropical diseases
Published: December 27, 2023
The Epidemiological Impact of Dengue in Colombia: A Systematic Review.
Journal: The American journal of tropical medicine and hygiene
Published: December 22, 2023
Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination.
Journal: The Journal of infectious diseases
Published: June 01, 2023
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study.
Journal: EClinicalMedicine
Published: May 24, 2023
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial.
Journal: The Lancet. Respiratory medicine
Published: April 19, 2023
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.
Journal: The Lancet. Global health
Published: February 22, 2023
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine.
Journal: medRxiv : the preprint server for health sciences
Published: December 16, 2022
Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue.
Journal: The American journal of tropical medicine and hygiene
Published: October 24, 2022
Last Updated: 09/26/2026